The role of asunercept as a selective CD95L inhibitor in cutaneous melanoma: Rationale and results from an enhanced TiRP model
| Hoofdauteurs: | , , , , , , |
|---|---|
| Andere auteurs: | |
| Formaat: | Conference item |
| Taal: | English |
| Gepubliceerd in: |
Elsevier
2020
|
| Samenvatting: |
|---|